Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) was the target of a large decline in short interest in May. As of May 15th, there was short interest totalling 13,800 shares, a decline of 42.5% from the April 30th total of 24,000 shares. Approximately 0.0% of the shares of the stock are sold short. Based […]